Ansell Exam Glove Micro-Touch® NitraFree™ X-Large NonSterile Nitrile Standard Cuff Length Textured Fingertips Pink Chemo Tested - Case of 10 - 6034514-CS
Ansell Exam Glove Micro-Touch® NitraFree™ X-Large NonSterile Nitrile Standard Cuff Length Textured Fingertips Pink Chemo Tested - Case of 10 - 6034514-CS
Regular price
$217.99
Sale price
$217.99
Regular price
Unit price
per
Shipping calculated at checkout.
50 In stock
Estimated deliver:
Flat-Rate Shipping from $8.25
Ansell Exam Glove Micro-Touch® NitraFree™ X-Large NonSterile Nitrile Standard Cuff Length Texture...
| Item Id | 697232 |
| MF Id# | 6034514 |
| Brand | Micro-Touch® NitraFree™ |
| Manufacturer | Ansell |
| Country of Origin | Malaysia |
| Application | Exam Glove |
| Color | Pink |
| Color Family | Pink |
| Cuff Style | Beaded Cuff |
| Fingertip Thickness Range | 6.1 mil to 8.0 mil Range |
| Fingertip Thickness: Typ.Values | 0.16 mm (6.3 mil) |
| Glove Exterior | Textured Fingertips |
| Glove Interior | Without Coating |
| Glove Length | Standard Cuff Length |
| Hand Compatibility | Ambidextrous |
| Is_Active_Vendor | Y |
| Is_DSCSA | N |
| Is_Discontinued | N |
| Is_Medical_Device | N |
| Length in Inches | 9.44 Inch |
| Lot_Tracking_Flag | N |
| Material | Nitrile |
| On_Allocation | N |
| Protection Level | Chemo Tested |
| Size | X-Large |
| Sterility | NonSterile |
| Supplier_ID | 487951 |
| Type | Low Dermatitis Potential |
| UNSPSC Code | 42132203 |
Features
- This glove is tested for use with the following 8 chemotherapy drugs: Vincristine Sulfate, Cyclophosphamide (Cytoxan), Doxorubicin Hydrochloride, 5-Fluorouracil, Methotrexate, Etoposide (Toposar), Paclitaxel (Taxol) and Thiotepa
- Does not contain any sulfur-based accelerators such as thiurams, carbamates, thiazoles, guanidine or thioureas
- In 2010-2011, Ansell will donate $2 per case sold of the Micro-Touch* NitraFree* to Susan G. Komen for the Cure*, with a guaranteed minimum donation of $25,000
- The textured fingertips of the glove provide extra protection for wet or dry grip and against slippage